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Introduction Immunization is a vital component in the drive to decrease global childhood
mortality, yet challenges remain in ensuring wide coverage of immunization and
full immunization, particularly in low- and middle-income countries. This study
assessed immunization coverage and the determinants of immunization in a
semi-rural area in The Gambia.
Methods Data were drawn from the Farafenni Health and Demographic Surveillance
System. Children born within the surveillance area between January 2000 and
December 2010 were included. Main outcomes assessed included measles, BCG
and DTP vaccination status and full immunization by 12 months of age as
reported on child healthcards. Predictor variables were evaluated based on a
literature review and included gender, ethnicity, area of residence, household
wealth and mother’s age.
Results Of the 7363 children included in the study, immunization coverage was 73%
(CI 72–74) for measles, 86% (CI 86–87) for BCG, 79% (CI 78–80) for three doses
of DTP and 52% (CI 51–53) for full immunization. Coverage was significantly
associated with area of residence and ethnicity, with children in urban areas and
of Mandinka ethnicity being least likely to be fully immunized.
Conclusions Despite high levels of coverage of many individual vaccines, delivery of
vaccinations later in the schedule and achieving high coverage of full
immunization remain challenges, even in a country with a committed childhood
immunization programme, such as The Gambia. Our data indicate
areas for targeted interventions by the national Expanded Programme of
Immunization.
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KEY MESSAGES
 Despite high levels of coverage of many individual vaccines, full immunization remains a challenge, even in a country
with a committed childhood immunization programme, such as The Gambia.
 Some groups of the population are potentially more at risk of defaulting on immunizations and there is discrepancy
between urban and rural settings.
 Although some of the barriers to immunization are understood, more evidence is needed as to how these can be
overcome in low-income countries.
Introduction
Immunization is recognized as one of the most cost-effective
interventions to prevent morbidity and mortality caused by
infectious diseases, particularly in a high-endemic setting (The
World Bank 1993, 1994; WHO, UNICEF 2005; WHO, UNICEF,
World Bank 2009). Vaccines prevent more than 2.5 million
child deaths each year and it has been shown that children who
receive all appropriate vaccinations by 9 months of age are less
likely to die than those who do not (Rutherford et al. 2009).
Immunization is therefore a key component of the drive to
decrease childhood mortality and to achieve Millennium
Development Goal 4—the reduction of under-five mortality
rates by two-thirds in 2015 (WHO, UNICEF 2005; WHO,
UNICEF, World Bank 2009).
Despite global progress in providing vaccinations, there still
remains a challenge in reaching those most vulnerable: the
poorest, most disadvantaged and remote communities.
Immunization coverage in low-income countries remains sig-
nificantly below the levels in middle- and high-income
countries (WHO, UNICEF, World Bank 2009; WHO 2010a,b).
Summarized data from national coverage rates can mask
inequalities in regional immunization coverage and even
countries with high national coverage rates and demonstrable
improvement in coverage continue to show socio-economic
disparities in coverage (Jamil et al. 1999; Burton et al. 2009;
Durrheim and Cashman 2010; Uddin et al. 2010).
In 1974, the Expanded Programme of Immunization (EPI)
was established by the WHO to ensure that all children in all
countries benefit from life-saving immunizations. The EPI in
The Gambia started in May 1979, covering the core diseases
tuberculosis (BCG vaccine), diphtheria, pertussis, tetanus
(combined in the DTP vaccine), measles, polio and yellow
fever. Hepatitis B (HBV) vaccine was phased in between 1986
and 1990, Haemophilus influenzae type B (Hib) vaccine in 1997
and, more recently, the conjugated pneumococcal vaccine
(PCV) in 2009.
In contrast to other developing countries, The Gambia has
consistently reported high national coverage rates for most
routine immunizations. WHO estimates of immunization cover-
age among 1-year-olds in The Gambia in 2009 indicate that, for
many immunizations (measles, yellow fever and third dose of
DTP, Hib, HBV and polio), coverage was above 95% (WHO
2011b). The full immunization schedule recommended in The
Gambia is summarized in Table 1. The Multiple Indicator
Cluster Survey (MICS), a national survey in The Gambia, shows
an increase in the percentage of children aged 12–23 months
immunized against specific infectious diseases between 2000
and 2006. However, the rate of full immunization (defined as
the number of children aged 12–23 months receiving three
doses of DTP, three doses of polio, BCG and measles vaccines
before their first birthday as a percentage of the total number of
children aged 12–23 months surveyed) decreased over this time
and in 2006 was only 55% nationally (Government of The
Gambia, UNICEF 2002; Government of The Gambia 2007).
Completion of the immunization schedule and achievement of
the United Nations target of full immunization coverage for
90% of children under 1 year remains a challenge, even in The
Gambia.
Immunization coverage, particularly in the developing world,
has been shown to be associated with several socio-economic
and demographic factors, such as parental education, economic
status, region of residence, age of the mother, ethnicity and
gender of the child (Hanlon et al. 1988; Bhuiya et al. 1995; Jamil
et al. 1999; Bosu et al. 2003; Waters et al. 2004; Hilber et al. 2010;
Sullivan et al. 2010) and these disparities are not necessarily
remedied by increasing the overall percentage of immunization
coverage (Jamil et al. 1999).
In the Farafenni region of The Gambia, an extensive
Demographic Surveillance System has been in place for many
years, through which immunization data are collected rou-
tinely. This provides a unique opportunity to assess the
immunization coverage, in particular full immunization and
to determine if variation exists in immunization coverage. This
analysis of socio-economic and demographic factors that might
influence immunization coverage aims to inform the EPI in The
Gambia and other settings.
Scientific and ethical approval was given by the joint MRC/
Gambia Government Scientific Co-ordinating Committee and
The Gambia Government/MRC Laboratories Joint Ethics
Committee (SCC 1244).
Methods
Study area
The Government is the major provider of health care in The
Gambia. Primary health care (PHC) is delivered via the PHC
strategy, adopted in 1979 to ‘make healthcare more accessible
and affordable to the majority of Gambians’ (Government of
The Gambia 2007), with a particular focus on rural settlements
with a population of more than 400. As part of the PHC
strategy, these rural areas have been served by volunteer village
health workers and traditional birth attendants (TBAs) since
the 1980s.
Maternal and Child Health (MCH) services have also been a
core part of the PHC strategy as it began including outreach
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services. MCH services are delivered via both static and mobile
health clinics with the core objectives to maintain high
immunization coverage levels, decrease maternal deaths and
improve child nutrition. Before 2009, a 5 Dalasi fee
(about US$0.17) was charged for a child healthcard and
then all subsequent care was free but now vaccinations,
along with all health care for children under five, are free of
charge.
This study was carried out in the North Bank East Health
Region of The Gambia, within the Farafenni Health and
Demographic Surveillance System (FHDSS). The FHDSS was
established in 1981, initially including only the rural villages
surrounding Farafenni town but has since expanded and the
surveillance area now comprises 42 rural villages, the town of
Farafenni and the area within a 5-km radius of the town
(designated the ‘peri-urban’ area).
There is one static MCH clinic in the region based in
Farafenni town running six MCH sessions per month. There
are three mobile clinics held monthly in the surrounding
villages. All villages in the region are within 3 km of a mobile
clinic and women mostly walk or use donkey carts to reach
there (North Bank East Health Region Public Health Officer,
personal communication).
The population covered by the FHDSS was 44 000 as of June
2007, made up of three main ethnic groups: Fula (21%),
Mandinka (34%) and Wolof (38%). It is predominantly young,
with an average age of 22 years and has a high level of fertility
with almost half of all women being in the reproductive age
bracket (15–49 years). The study area is relatively poor; most
houses are constructed of mud brick and only 3% of the rural
and 45% of the urban population have electricity. The study
area and population under surveillance are described in more
detail elsewhere (MRC 2004).
Data
Data for this study were drawn from the FHDSS. Demographic
and immunization data are collected during 4-monthly rounds
whereby every household is visited and details of every
individual in the household updated, including new members
(through birth or entry into the surveillance area). Full details
of the FHDSS process and procedures are documented else-
where (MRC 2004). For this analysis, a snapshot of the FHDSS
was taken after update round 62, which occurred between 1
September 2010 and 31 December 2010.
Data on the immunization status of children under 5 years of
age have been collected routinely since 2005 as part of the
standard FHDSS process. Data on the immunization status of
children born before 2005 were entered retrospectively during a
survey in 2005 which covered children aged five or under at the
time. All children born after 1 January 2000 who had reached
1 year of age by the final data collection round, and for whom
immunization data had been collected, were included in the
analysis.
In the analysis, immunization status was interpreted as
‘immunized’ for all those who had a vaccination date recorded
and ‘not immunized’ for all children who had no vaccination
date recorded in the FHDSS. In the majority of cases (98%),
immunization data were captured from the child healthcard. If
no healthcard was available (2% of children in our analysis),
immunization data were based on caregiver’s recall.
Socio-economic details including household head’s occupa-
tion, ownership of assets, water supply, toilet facilities, main
materials of walls, roof and floor of accommodation, access to
electricity and income were elicited through interviewer-
administered questionnaires as part of a household survey
conducted across the surveillance area between April and June
2007. For this analysis, a wealth index was created using
principal components analysis (PCA), based on the ownership
of the individual assets included in the household survey
(radio; TV; telephone; refrigerator; iron or wooden bed; cart;
bicycle; motorbike or scooter; car, truck or tractor) and publicly
provided resources, such as electricity, water and toilet facilities.
A similar approach in measuring wealth has been used by
others (Gwatkin et al. 2000).
Outcome measures
For all analyses, the primary outcome of interest was coverage
of immunization. Immunization coverage was calculated as:
Number of children who received the immunization
All children eligible for immunization who were surveyed
regarding immunizations
100
Coverage was calculated for the individual vaccinations listed in
Figure 1 and for full immunization at 1 year (defined as
receiving BCG, three doses of OPV, three doses of DTP and one
dose of measles vaccine by 1 year of age). This is the definition
of full immunization used in the national MICS in the Gambia
and therefore was used here to enable comparison.
In addition, the proportions of children who received more
than half of the 16 recommended vaccine doses in the national
schedule, and the proportion who received all 16, were
calculated to further assess programme performance.
Table 1 The Gambia immunization schedule
Timing Vaccinations
Birth BCG, first dose of polio, first dose of HBV
2, 3 and 4
months
DTP/Hib/HBV combined; second, third, fourth
dose of polio; PCV
9 months Measles, yellow fever, fifth dose of polio
16 months DTP/Hib/HBV combined
18 months Sixth dose polio
Plus vitamin A every 6 months (from 6 months of age till 59 months)
Source: WHO vaccine-preventable diseases: monitoring system 2010 global
summary (WHO 2010a,b).
Figure 1 Vaccinations selected as measures of immunization coverage.
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The outcome measures chosen for the analysis of possible
factors influencing immunization were:
 BCG immunization as a measure of the system of delivery of
vaccines at birth;
 Three doses of DTP vaccine (DTP3) as a measure of
consistency of immunization coverage and as an ‘indicator’
of coverage of other 2/3/4 month vaccines;
 Measles immunization as a measure of consistency of
delivery and capacity of the system to ensure follow-up of
children above 6 months of age; and
 Full immunization at 1 year (defined as receiving BCG, three
doses of OPV, three doses of DTP and one dose of measles
vaccine by 1 year of age) as a measure of the proportion of
the population of children who have an adequate level of
acquired immunity and the capacity of the system to ensure
adequate follow-up to achieve this.
Predictor variables
Variables that might affect immunization coverage, therefore of
interest in this study, were selected from a review of the
relevant literature. These variables are listed in Figure 2.
Statistical analysis
Immunization coverage, with 95% confidence intervals, was
calculated for the total population over the whole time period
2000–9 and stratified by area of residence. Multiple logistic
regression analysis was carried out on the set of individuals for
which observations were available for all predictor variables.
Results were adjusted for year of birth to account for any
variations in coverage over time. Correlation between predictor
variables was also tested for.
Predictor variables for inclusion in the multiple regression
models were first tested individually for significance of the
relationship with each outcome variable using univariable
logistic regression (i.e. unadjusted analyses). Those resulting
in P-value <0.25 were included in an adjusted analysis, as
recommended by Hosmer and Lemeshow (2000). The variables
‘mother’s age’ and ‘sex of the child’ did not meet this
significance level and were not included in the final model.
The Hosmer and Lemeshow goodness-of-fit test was used to
check the fit of the final model. The software package STATA
10 (StataCorp 2007) was used for all statistical analysis.
Results
The total number of births in the FHDSS population between 1
January 2000 and 31 December 2009 was 20 514. As of 31
December 2010, 7363 (36%) of these had been surveyed
regarding vaccination data. Amongst the surveyed group, a
greater proportion were from rural villages (54%) compared
with the general population (40%) (P< 0.001). There were also
small but significant differences in the distribution of ethnic
group, household head’s occupation, mother’s age and wealth
quintile (Table 2). These factors have been adjusted for in the
analyses.
The variables ‘area of residence’ and ‘wealth’ were moderately
correlated (r¼ 0.519) but no other variables showed any
appreciable correlation and the Hosmer and Lemeshow
goodness-of-fit test indicated the model was a good fit.
Immunization coverage
Of the 7363 individuals included in this analysis, 98% (7217)
had a child healthcard. Of those children who had a healthcard,
97% (6991) had at least one vaccination recorded. The
percentage with no vaccinations was roughly the same in
rural and urban areas (3%) and slightly lower in peri-urban
areas (2%).
Immunization coverage in this population varied over the
study time period. BCG immunization coverage rose steadily till
2005 and then plateaued at >90%. Coverage of measles, DTP3
and full immunization fluctuated.
Of note is the trend that vaccines given at older age, e.g.
measles, yellow fever and third dose of HBV, had lower
coverage than those given at an earlier age, such as BCG and
first dose of HBV. Measles vaccine coverage was only 73% (CI
72–74%) compared with coverage of BCG vaccine of 86% (CI
86–87%) and HBV1 at 92% (CI 92–93%).
In this sample, only 34% (2473) of children received the
fourth dose of DTP and of those, less than half received it
within 18 months.
A striking feature was the comparatively low coverage of full
immunization in this population. Only 52% (3829) of the
children surveyed had received BCG, three doses of OPV, three
doses of DTP and measles vaccine by 1 year of age.
The proportion of children receiving all vaccines (and all
doses) offered in the national schedule provides an indication
of immunization delivery. In this study population, although
only 20% of all children received all 16 vaccine doses offered,
86% of children received at least half of the total doses offered
and 67% received 12 or more of the 16 doses.
Immunization coverage for the whole sample and by area of
residence, alongside national estimates from the MICS report
2006 and WHO 2009, is summarized in Table 3.
Factors affecting immunization coverage
We subsequently analysed the factors potentially affecting
immunization coverage. The results of multiple regression
analysis of immunization coverage and socio-demographic
variables are presented in Table 4.
Area of residence
Among the urban children, the coverage of full immunization
was only 47% compared with 56% in rural areas. For all
vaccines except HBV, coverage was higher in rural than urban
areas. Peri-urban areas also had higher coverage of measles,
BCG, DTP3, polio3 and yellow fever immunization than urban
areas.
Figure 2 Predictor variables selected for regression analysis.
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For all outcome variables except measles immunization, mul-
tiple regression indicates that children living in an urban area
were less likely to be immunized than those living in rural areas
(BCG OR 0.54, 95% CI 0.44–0.66, P< 0.001; DTP3 OR 0.74, 95% CI
0.64–0.87, P< 0.001; full immunization OR 0.73, 95% CI
0.64–0.84, P< 0.001). Those living in peri-urban areas were also
less likely to be immunized against BCG or to be fully immunized
than in rural areas (BCG OR 0.69, 95% CI 0.54–0.88, P¼ 0.003;
full immunization OR 0.72, 95% CI 0.61–0.85, P< 0.001).
Ethnicity
Children of Mandinka ethnicity were less likely to be
immunized compared with those of Fula or Wolof ethnicity.
The results indicate that those of Fula ethnicity were more
likely than Mandinka to receive BCG vaccine (OR 1.50, 95% CI
1.21–1.86, P< 0.001), Measles vaccine (OR 1.26, 95% CI 1.07–
1.49, P¼ 0.005) and full immunization, although
non-significant (OR 1.15, 95% CI 1.00–1.32, P¼ 0.060).
Children of Wolof ethnicity were more likely than Mandinka
to receive BCG vaccine (OR 1.52, 95% CI 1.28–1.81, P< 0.001),
measles vaccine (OR 1.19, 95% CI 1.04–1.36, P¼ 0.012) or to be
fully immunized (OR 1.14, 95% CI 1.01–1.28, P¼ 0.032).
There was no significant association between different ethnic
groups and coverage of DTP3.
Wealth
There was no significant association between wealth and
immunization coverage. There was a slight apparent trend in
BCG coverage with increasing coverage for higher wealth
quintiles but this was not significant except for comparison of
the wealthiest to the least wealthy quintiles (OR 1.49, 95% CI
1.09–2.04, P¼ 0.011).
Table 2 Comparison of characteristics of children for whom immunization data were available and the total population of births
Immunization data No immunization data Total population Chi-square
P-value
% n % n % n
Gender 0.092
Male 50.5 3717 49.0 6479 49.7 10 196
Female 49.5 3643 51.0 6669 50.3 10 312
Unknown 0.0 3 0.0 3 0.0 6
Area <0.001
Rural 54.2 3989 32.5 4271 40.3 8260
Urban 33.6 2472 55.6 7316 47.7 9788
Peri-urban 12.2 902 11.9 1564 12.0 2466
Unknown 0.0 0 0.0 0 0.0 0
Ethnic group <0.001
Fula 21.6 1589 22.0 2864 21.8 4461
Mandinka 31.8 2339 29.0 3765 29.8 6115
Wolof 42.9 3157 43.0 5636 43.0 8813
Other 3.7 276 6.0 637 5.4 1114
Unknown 0.0 2 0.0 9 0.0 11
Mother’s education level <0.001
<3 years 17.3 1276 12.2 1606 14.0 2882
>3 years 6.3 464 3.9 514 4.8 978
Unknown 76.4 5623 83.9 11 031 81.2 16 654
Occupationa <0.001
Farmer 48.6 3576 31.7 4165 37.7 7741
Craftsman 0.3 23 0.3 37 0.3 60
Tradesman 11.1 819 16.7 2199 14.7 3018
Retired 6.0 442 4.9 641 5.3 1083
Other 23.4 1721 25.0 3294 24.5 5015
Unknown 10.6 782 21.4 2185 17.5 3597
Median (25th, 75th) n Median (25th, 75th) n Median (25th, 75th) n Rank sum
P-value
Wealth quintile 2 (1, 3) 6352 2 (1, 3)b 10 036 2 (1, 3) 16 388 <0.001
Mother’s age (years) 26 (21, 32) 7126 25 (21, 30) 11 073 26 (21, 31) 18 199 <0.001
aOccupation of household head.
bRank sum was higher than expected for those not surveyed indicating that wealth was slightly higher amongst those who were not surveyed.
ACHIEVING COMPREHENSIVE CHILDHOOD IMMUNIZATION 197
Table 4 Unadjusted and adjusted analysis of association between vaccination coverage and predictor variables
Variable Category Unadjusted OR Adjusted OR (n¼ 6350)
OR CI P-value OR CI P-value
Full immunization
Area Rural (ref) 1.00 1.00
Urban 0.72 0.65–0.79 <0.001 0.73 0.64–0.84 <0.001a
Peri-urban 0.72 0.62–0.83 <0.001 0.72 0.61–0.85 <0.001a
Sex Male (ref) 1.00
Female 1.03 0.94–1.13 0.57 – – –
Ethnic group Mandinka(ref) 1.00 1.00
Fula 1.14 1.00–1.29 0.046 1.15 1.00–1.32 0.060
Wolof 1.16 1.04–1.29 0.008 1.14 1.01–1.28 0.032a
Other 0.90 0.70–1.16 0.418 1.10 0.82–1.46 0.537
Wealthb Quintile 1: lowest (ref) 1.00 1.00
Quintile 2 0.79 0.68–0.92 0.003 0.82 0.70–0.95 0.010a
Quintile 3 0.89 0.76–1.05 0.164 0.97 0.82–1.14 0.705
Quintile 4 0.81 0.69–0.94 0.007 0.92 0.78–1.09 0.330
Quintile 5 0.70 0.59–0.83 <0.001 0.89 0.72–1.09 0.251
Mothers age (years) – 1.00 0.99–1.01 0.272 – – –
BCG
Area Rural (ref) 1.00 1.00
Urban 0.79 0.68–0.91 0.001 0.54 0.44–0.66 <0.001a
Peri-urban 0.88 0.72–1.09 0.255 0.69 0.54–0.88 0.003a
Sex Male (ref) 1.00
Female 1.03 0.90–1.18 0.659 – – –
Ethnic group Mandinka (ref) 1.00 1.00
Fula 1.36 1.13–1.63 0.001 1.50 1.21–1.86 <0.001a
Wolof 1.42 1.22–1.65 <0.001 1.52 1.28–1.81 <0.001a
Other 1.05 0.74–1.48 0.790 1.21 0.80–1.82 0.364
(continued)
Table 3 Percentage of children who received vaccination by area of residence for each vaccine and national estimate comparators
Vaccine All areas
(n¼ 7363)
Rural
(n¼ 3989)
Urban
(n¼ 2472)
Peri-urban
(n¼ 902)
WHO
2009a
MICS
3 %b
FHDSS 2008c
(n¼ 662)
%
coverage
95% CI %
coverage
95% CI %
coverage
95% CI %
coverage
95% CI
BCG 86 (86–87) 88 (86–88) 85 (83–86) 86 (84–88) 94 98.7 94
DTP3 (at least three doses) 79 (78–80) 82 (80–83) 76 (74–77) 79 (77–82) 98 86.8 67
Polio (at least three doses) 88 (87–89) 89 (88–90) 86 (84–87) 89 (87–91) 97 87.6 81
Measles 73 (72–74) 75 (73–76) 70 (68–71) 72 (69–75) 96 92.4 67
Yellow fever 72 (71–73) 74 (73–75) 69 (67–71) 72 (69–75) 96 83.5 67
Full immunizationd 52 (51–53) 56 (54–57) 47 (45–49) 47 (44–51) – 55.3 48
Vitamin A (at least one dose) 43 (41–44) 39 (37–40) 47 (45–49) 47 (43–50) – – 68
Hepatitis B (at least one dose) 92 (92–93) 92 (91–93) 93 (92–94) 92 (90–94) – – 95
Hepatitis B (three doses) 69 (68–70) 70 (69–72) 68 (66–69) 68 (65–71) 98 – 51
aData source: WHO Gambia Immunization profile: http://apps.who.int/immunization_monitoring/en/globalsummary/countryprofileresult.cfm?C¼gmb, accessed
12 November 2012.
bMICS 3 measures percentage of children aged 12–23 months having received specified vaccine at the time of the survey.
cFHDSS single year comparator for WHO 2009 data.
dIncludes three doses of DTP, three doses of OPV, BCG and measles vaccine by 1 year of age.
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Discussion
This study highlights that despite high coverage for some
immunizations, serious gaps exist even in The Gambia, and
reaching the United Nations target of 90% of children being
fully immunized by 1 year of age (and the Government of The
Gambia target of 100% by 2015) remains a challenge. Only 52%
of children achieved full immunization by 1 year of age over the
study period, with the proportion even lower (47%) among
Table 4 Continued
Variable Category Unadjusted OR Adjusted OR (n¼ 6350)
OR CI P-value OR CI P-value
Wealthb Quintile 1: lowest (ref) 1.00 1.00
Quintile 2 0.78 0.63–0.97 0.028 0.80 0.63–1.00 0.053
Quintile 3 1.05 0.83–1.34 0.663 1.19 0.92–1.54 0.185
Quintile 4 1.01 0.80–1.26 0.953 1.21 0.94–1.56 0.129
Quintile 5 1.05 0.82–1.35 0.697 1.49 1.09–2.04 0.011a
Mother’s age (years) – 1.00 0.99–1.01 0.572 – – –
Measles
Area Rural (ref) 1.00 1.00
Urban 0.78 0.70–0.87 <0.001 0.90 0.77–1.05 0.174
Peri-urban 0.88 0.75–1.04 0.127 0.91 0.75–1.09 0.301
Sex Male (ref) 1.00
Female 0.97 0.87–1.07 0.543 – – –
Ethnic group Mandinka(ref) 1.00 1.00
Fula 1.18 1.02–1.36 0.025 1.26 1.07–1.49 0.005a
Wolof 1.14 1.01–1.29 0.028 1.19 1.04–1.36 0.012a
Other 0.88 0.67–1.15 0.355 0.98 0.72–1.35 0.921
Wealthb Quintile 1: lowest (ref) 1.00
Quintile 2 0.82 0.69–0.97 0.023 0.86 0.72–1.03 0.274
Quintile 3 0.83 0.69–1.00 0.047 0.92 0.76–1.12 0.481
Quintile 4 0.83 0.70–0.99 0.042 0.95 0.78–1.15 0.646
Quintile 5 0.77 0.63–0.93 0.006 0.97 0.77–1.23 0.718
Mother’s age (years) – 1.00 0.99–1.01 0.694 – – –
DTP3
Area Rural (ref) 1.00 1.00
Urban 0.72 0.65–0.81 <0.001 0.74 0.64–0.87 <0.001a
Peri-urban 0.87 0.74–1.03 0.098 0.85 0.71–1.02 0.083
Sex Male (ref) 1.00
Female 1.00 0.90–1.11 0.986 – – –
Ethnic group Mandinka(ref) 1.00 1.00
Fula 1.02 0.88–1.18 0.801 1.03 0.88–1.21 0.707
Wolof 1.11 0.99–1.26 0.082 1.12 0.98–1.28 0.1
Other 0.79 0.61–1.04 0.088 0.93 0.68–1.27 0.651
Wealthb Quintile 1: lowest (ref) 1.00 1.00
Quintile 2 0.93 0.78–1.11 0.397 0.95 0.79–1.14 0.565
Quintile 3 0.91 0.76–1.10 0.33 0.97 0.80–1.17 0.727
Quintile 4 0.80 0.67–0.96 0.013 0.89 0.74–1.07 0.214
Quintile 5 0.79 0.65–0.95 0.014 1.00 0.79–1.26 0.982
Mother’s age (years) – 1.00 0.99–1.01 0.627 – – –
(ref) denotes baseline category of the variable used for regression.
Variables selected for inclusion in multivariable regression if unadjusted P-value for any category of the variable <0.25.
aSignificant adjusted OR, P< 0.05.
bWealth quintile calculated using PCA including ownership of: radio; tv; telephone; refrigerator; iron or wooden bed; cart; bicycle; motorbike or scooter; car,
truck or tractor; and if dwelling has electricity, water piped into compound or dwelling; flush toilet.
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children living in the urban area, indicating that a large
proportion of children in this population are not benefiting
from the protection against common childhood infections that
the immunization schedule aims to provide.
Our data are in accordance with the Gambia MICS 2006
report, where national coverage of full immunization is simi-
larly reported to be only 55.3% (Government of The Gambia
2007). Rates of full immunization in other developing countries
vary, with low rates reported in India (less than one-third of
rural children and one-half of urban children) and Ethiopia
(49%) (Pande and Yazbeck 2003; Tadesse et al. 2009). In
Bangladesh, high national coverage (75%) conceals low cover-
age of full immunization in rural areas (42%) suggesting that
full immunization remains a challenge for developing countries
(Uddin et al. 2010).
Despite the fact that The Gambia has reported consistently
high national immunization coverage for many years, this study
highlights room for improvement, both with overall immun-
ization coverage in some parts of the country and the
distribution of this coverage. The proportion of children
receiving no vaccines at all is very low (3%) and the coverage
of BCG immunization is high, indicating that the system of
delivering immunizations at or close to birth works well.
However, coverage of later immunizations, such as measles,
given at 9 months, is much lower indicating that challenges
still exist in follow-up of children throughout the immunization
schedule.
Several other studies in developing country settings have
found a similar pattern with a drop-off in both measles vaccine
coverage and full immunization despite high BCG coverage,
indicating that drop-out is a common challenge (PATH 2002;
Odusanya et al. 2008; Mutua et al. 2011).
Coverage of measles immunization of only 73% is of concern
and poses a risk to both individual protection and to herd
immunity within the community. Cutts (1993) suggests that
coverage of at least 90% is required to achieve a marked
reduction in measles incidence in Africa; and as high as 98% for
elimination. Measles is still a contributor to under-five mortal-
ity in The Gambia, accounting for 1% of all under-five mortality
in 2008 (WHO 2011a).
DTP vaccine is recommended as multiple doses at 2, 3 and
4 months and a booster at 16 months. The proportion of children
receiving the first three doses of DTP is commonly used as
measure of how well immunization programmes are functioning
(WHO, UNICEF, World Bank 2009). Though even one dose of a
vaccine will usually provide some degree of immunity, the full
vaccine schedule is recommended to achieve long-lasting, full
immunity. In this study, only 79% of children received three or
more doses of DTP. Given that other recommended vaccinations,
such as Hib and PCV, are delivered at the same point in the
schedule as DTP, the low coverage of DTP3 could be a predictor of
low coverage of Hib and PCV as well.
The high proportion of children receiving at least one vaccine
dose, high coverage of BCG immunization and 67% receiving
most of the recommended vaccine doses (12/16) suggest that
some of the logistical or infrastructure related barriers to
vaccination reported in other developing countries are not an
obstacle in The Gambia. TBAs and PHC workers, an integral
part of the MCH outreach programme, also play a role in
encouraging women to attend MCH clinics. In the surveillance
area the regular fieldworker visits every 4 months, and as part
of the FHDSS rounds these visits also act as a reminder and
communication route with every household regarding immuni-
zation services. Capacity issues and insufficient health workers
are however recognized issues in The Gambia. This can lead to
long queues at immunization clinics, especially in the urban
areas; which have previously been reported by women as a
deterrent from attending immunization clinics (Cassell et al.
2006).
Non-uptake of immunization can be a consequence of either
lack of acceptance or willingness but inability to access
immunization services, e.g. due to associated costs. Even in a
system where immunization is free, the indirect costs such as
transport and opportunity costs may be a deterrent for some
mothers to get their children immunized, despite general
acceptance and robust provision of immunization services
(Jamil et al. 1999; Canavati et al. 2011). Cassell et al. (2006)
found that non-uptake in The Gambia was usually related to
inability to take children to immunization clinics or mothers
mistakenly believing their children are fully immunized when
they are not, rather than resistance to immunization per se.
The factors determining receipt of immunization are complex
and interlinked. In this population, immunization coverage
varied by area of residence. In contrast to what has been found
in other developing countries (Pande and Yazbeck 2003; Uddin
et al. 2010), immunization coverage was higher in rural areas
than urban townships, as also confirmed by Cassell (2006) and
the MICS 2006 (Government of The Gambia 2007).
These differences are small in magnitude but strongly
significant and consistent across all outcomes. Few qualitative
studies of vaccine coverage (or default) in low- to middle-
income countries exist so evidence for the reasons for default
among certain groups is limited. The work pattern of the
mother or primary caregiver is a possible explanation for higher
immunization coverage in rural areas (Canavati et al. 2011).
Local EPI staff report anecdotally that mother’s in urban areas
are more likely to be in formal work than their rural
counterparts which might interfere with their ability to attend
immunization clinics, where they are often required to wait
most of the day (EPI Officer, Personal communication). Data
on mother’s occupation were not captured for this analysis so
this hypothesis was not tested. Although clinics are often closer
and more accessible in urban areas, Cassell (2006) reported that
urban mothers experience more problems with crowding and
long waits at the clinics than mothers from rural villages and
that cohesive family and social networks in rural villages play a
role in facilitating mothers’ ability to attend the clinic through
‘social orchestration’, which is less common in urban areas.
Furthermore, in rural areas, the TBA and PHC workers both
play a role in encouraging mothers to attend the MCH clinics.
These roles do not formally exist in urban areas and it has been
shown in other low-income settings that household visits by
health workers positively influence immunization coverage
(Jamil et al. 1999).
We found that children of Mandinka ethnicity were less likely
to be immunized than those of either Fula or Wolof ethnicity.
There is minimal literature on ethnic differences in healthcare
utilization in The Gambia with which to compare these results.
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Anecdotally, local health officers in the North Bank East Region
report lower engagement of Mandinka communities with MCH
services in general (North Bank East Health Region Public
Health Officer, personal communication). The consistency of
the ethnicity association across all outcomes in this study
suggests that further investigation of the potential ethno-
cultural differences in access to, or acceptance of, immunization
is warranted.
Family wealth has repeatedly been shown to influence
immunization coverage in many developing countries, usually
with the poorest being least likely to be immunized. The
underlying hypothesis is that the poorest are most disadvan-
taged by the time, logistics and opportunity costs involved in
accessing immunization services (Jamil et al. 1999; Tadesse et al.
2009; Mutua et al. 2011). The lack of association between
immunization and family wealth in this study could be
expected in a setting where immunizations are free at the
point of care and robust outreach services are in place to ensure
accessibility in rural areas. Household wealth was measured
using a one-off household asset survey carried out in 2007.
Comparative data for earlier years were not available. It is
possible that relative changes in household wealth over the
study time period could have occurred, influencing the lack of
association between vaccine coverage and wealth found here.
The strengths of this study include a rigorous and frequent
data collection process, a reasonably stable population; and few
significant changes to the delivery of the immunization
programme over the time span of the study.
However our study also has some limitations. Some potential
confounding variables of interest were not available for analysis
such as use of antenatal care and mother’s education which has
often been found to be associated with immunization coverage
in low- to middle-income countries (Bosu et al. 2003; Hilber
et al. 2010; Sullivan et al. 2010). It is unclear whether these
variables would have influenced the associations found here. In
addition, supply side factors, such as vaccine availability,
adverse events or environmental catastrophe have potential to
impact immunization coverage but the authors found no
evidence of these factors affecting the FHDSS area.
Despite consistent data collection processes across the FHDSS
and fieldworkers being encouraged to ask about immunizations
for all households, immunization data have been collected only
for a subset of the population with a higher proportion of rural
children surveyed with respect to immunizations. Although the
sample for which immunization data were collected was shown
to be similar, in terms of a number of demographic character-
istics, to the general population, it is possible that there are
additional factors that differ in distribution between these
groups which were not adjusted for. Regression analysis was
limited to the subset of children for whom data on all predictor
variables were available (n¼ 6350, 86%); however, this subset
was representative of the whole sample in terms of demo-
graphic characteristics.
All children born during the study period, for which
immunization data were available, were included in the
analyses. It is reported that 5% of children born in this area
die during their first year (Jasseh et al. 2011). Given that
children do not always receive immunizations exactly according
to the schedule it is impossible to quantify exactly how many of
these children would have been immunized had they survived
longer. However, assuming some would have gone on to receive
further immunizations, coverage rates for the vaccines received
later in the first year are likely to be slight underestimates in
our results.
Immunization data on children born before 2005 were
collected retrospectively. Given immunization data were taken
from the child’s healthcard for 98% of children, retrospective
data entry is unlikely to have lead to any serious bias.
A key question of course remains: what is the impact of the
immunization coverage levels on disease and mortality? Some
recent research reports declines in child mortality in The
Gambia, against a backdrop of fairly consistent national
immunization rates, suggesting that this improvement might
be due to factors such as a reduction in malaria mortality,
improved oral rehydration for diarrhoea and better sanitation
(Hill et al. 2000; Jasseh et al. 2011). However, the importance of
the protective effect of immunization against child mortality
should not to be overlooked due to the high attributable risk of
mortality from lack of immunization (Rutherford et al. 2009).
Given the role that measles still plays in under-five mortality in
The Gambia, the immunization coverage rate of 73% indicates
there is further scope for decreasing mortality by improved
immunization. Equally, with pneumonia still a significant cause
of childhood mortality and recent introduction of the PCV,
improved coverage rates of immunizations delivered at 2, 3 and
4 months, which now include PCV, have potential to further
decrease mortality.
Given the low coverage of full immunization, it would be
valuable to gauge the impact of lack of full immunization on
levels of protective antibody, in particular through to adult-
hood—often secured through delivery of booster vaccine doses.
This is especially pertinent in women of child-bearing age as
immunity in adulthood influences the immunity provided to
infants through maternal antibodies (Jones et al. 2011).
Initiatives to improve rates of full immunization need to
respond to the barriers to immunization. While this analysis is
useful for determining the gaps in immunization coverage and
the socio-demographic factors associated with coverage, further
qualitative research is needed to better understand why
differences exist in different groups of the population and
what barriers prevent full immunization. Evidence of effective
interventions in response to these barriers is also required.
Current evidence indicates that patient reminders help to
increase immunization rates; however, most studies using
reminders and patient recall have been carried out in developed
countries and such systems usually require technologies that
may be lacking in low-income countries (Szilagyi et al. 2002;
Oyo-Ita et al. 2011). Evidence also suggests that interventions
such as facility-based health education, evidence-based discus-
sions and targeted information campaigns can improve im-
munization coverage (Oyo-Ita et al. 2011). Such interventions
are feasible in low-income countries.
Conclusions
Immunization remains an important tool to reduce childhood
mortality with additional vaccines now available and ready to
be taken up. This study highlights that, despite high levels of
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coverage of many individual vaccines, full immunization
remains a challenge, even in a country with a committed
childhood immunization programme, such as The Gambia. We
identified groups of the population who are potentially more at
risk of defaulting on immunizations. The results of this study
can be used to target the groups with lower immunization
coverage and to encourage further research into how barriers to
full immunization can be overcome. Interventions such as
information campaigns and catch up campaigns, targeted
specifically to those with lower immunization coverage such
as Mandinka ethnic groups and focused on immunizations late
in the schedule, should be explored by the Gambia EPI.
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